Model 2 will occupy market like the Ford F has been doing for decades
Laduree
Posts
-
-
Massive lay off = stock price surge ( look at Facebook)
-
Only cheap cars can occupy the market. Let the majority low income families buy their first Tesla
-
The analysts who estimated retail sales higher than previous holiday seasons are the Wall Street Xi. The high estimate was planned to benefit shorts.
-
Shorting TSM is equivalent to shorting an Ukrainian business and aiding Russia / China
-
AAPL counts on TSM
-
The answer is institution bulls have left the NVAX game and this gives control to hedge fund shorts. Good news do not attract whales anymore. This has nothing to do with science or cash flow or sales. This is just price action beyond the control of retail investors or retail shorts.
-
Flu vaccines will make money but sales doesn’t mean boosting price action, at least MMs or institutions aren’t necessarily viewing good sales the same way as retailer traders. Just look up tickets for these flu vaccines manufacturers and if any of them are trading above $100
https://www.fda.gov/vaccines-blood-biologics/lot-release/influenza-vaccine-2021-2022-season
Seqirus
GlaxoSmithKline Biologicals
Protein Sciences Corporation
ID Biomedical Corporation
MedImmune
Sanofi -
Vaccine Companies with only ONE product: NVAX, BNTX, MRNA
-
Most of posts sound swing traders
-
Flight cancellations do not refund flight fares paid, only credit vouchers are issued
-
Just remember BioNTech doesn’t have its own factories. If it attempted to submit EAU on its own without partnership with Pfizer, most likely it would fail a long way like Novavax did. Stan should have paired with big factories and agreed to share 50/50 last year instead of trying on his own. He was close minded and greedy and tried to milk every dollars. Lesson learned.
-
Approvals by foreign countries are not catalysts anymore. Hope for a bounce at news of FIRST deliveries to EU and WHO in Jan before weak ER in Feb.
-
Submitting SII in CMC package to FDA means domestic factory problems are still not fixed.
-
The November news about company spendings implies BIG expenses in 4Q21. Land js so expensive today. This will damage 2021 earning report released in early Feb.
Novavax, a clinical stage vaccine company that is currently developing a COVID-19 vaccine, has announced plans to expand into a new R&D, manufacturing, and office facility, and has purchased additional land in Montgomery County.
-
Does the CMC package submitted to FDA include domestic factories in Maryland ?? Does NVAX actually ask FDA to review imported vaccines from India to be used in domestic market ???
-
Airlines do not refund tickets. They only credit the canceled flights to your accounts. 4Q sales was sealed on book for ER.
-
Being Emotional is traders’ biggest enemy self
-
All the US dollars investment in this company is to benefit our European relatives.
-
When will Novavax submit CMC and GMP to FDA before green light to submit EAU ?
https://www.fda.gov/vaccines-blood-biologics/general-biologics-guidances/cmc-and-gmp-guidances
TSLA
TSLA
TSLA
TGT
TSM
TSM
NVAX
NVAX
NVAX
NVAX
JETS
NVAX
NVAX
NVAX
NVAX
NVAX
JETS
NVAX
NVAX
NVAX